JayGordonCourtrightMD

Oncology • Dallas, TX

Texas Oncology - Medical City Dallas

Join to view full profile

Dr. Courtright is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Courtright's full profile

Already have an account?

Office
7777 Forest Ln
Bldg D, Suite 400
Dallas, TX 75230
Phone+1 972-566-7790

Fax+1 972-566-7996
Is this information wrong?

Education & Training

University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 1999 - 2001
University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 1996 - 1999
University of Oklahoma College of MedicineClass of 1996

Certifications & Licensure

TX State Medical License 2003 - 2024
OK State Medical License 1997 - 2001

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma Start of enrollment: 2019 Oct 15
Terminated
Phase 1, Phase 2
Roles: Principal Investigator

Publications & Presentations

PubMed

81 citations
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study.
Chung-Han Lee, Amishi Yogesh Shah, Drew W. Rasco, Arpit Rao, Matthew H. Taylor, Christopher Di Simone, James J. Hsieh, Alvaro Pinto, David R. Shaffer, Regina Gironés S...> ;The Lancet. Oncology. 2021 Jul 1
259 citations
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, ...
Thomas Powles, Tibor Csőszi, Mustafa Ozguroglu, Nobuaki Matsubara, Lajos Géczi, Susanna Y-S Cheng, Yves Fradet, Stéphane Oudard, Christof Vulsteke, Rafael Morales Barr...> ;The Lancet. Oncology. 2021 Jul 1
126 citations
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial
Julie R. Nangia, Tao Wang, Cynthia Osborne, Polly A. Niravath, Kristen Otte, Steven W. Papish, Frankie A. Holmes, Jame Abraham, Mario E. Lacouture, Jay Courtright, Ric...> ;JAMA. 2017 Feb 14

Abstracts/Posters

Debulking Eliminates Need for Hospitalization Prior to Initiating Frontline Venetoclax Therapy in Previously Untreated CLL Patients: A Phase 3b Study
Jay Courtright, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Medical City DallasDallas, Texas